Form 4: Charles River Laboratories Executive Birgit Girshick Acquires Shares
SEC Form 4 Filing
Birgit Girshick, Corporate Executive VP & COO of Charles River Laboratories, purchased 1,514 shares of common stock at $164.63 per share on February 20, 2025.
Summary
- On February 20, 2025, Birgit Girshick, Corporate Executive VP & COO of Charles River Laboratories International, Inc. (CRL), acquired 1,514 shares of common stock.
- The purchase price was $164.63 per share.
- Following the transaction, Girshick directly owns 55,058 shares of Charles River Laboratories International, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. An executive purchasing shares can be seen as a positive signal, but it's a single transaction and doesn't provide definitive insight.
Positives
- Executive's purchase of company stock may signal confidence in the company's future performance.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's prospects. Purchases by executives are often seen as a positive sign.
Stakeholder Impact
- Shareholders may view the executive's stock purchase as a positive indicator of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 02/20/2025 | Date of the transaction: Birgit Girshick purchased 1,514 shares of CRL common stock. |
Keywords
Charles River Laboratories, CRL, Birgit Girshick, stock purchase, Form 4, insider trading, executive, ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.